These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 4281339

  • 1. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG, Green AR.
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [Abstract] [Full Text] [Related]

  • 2. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR, Youdim MB.
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
    Grahame-Smith DG.
    Br J Pharmacol; 1971 Dec; 43(4):856-64. PubMed ID: 4261561
    [Abstract] [Full Text] [Related]

  • 4. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR.
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [Abstract] [Full Text] [Related]

  • 5. Effect of lithium on brain 5-hydroxytryptamine metabolism in mice.
    Shaw JP, Ratcliffe F.
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):116-24. PubMed ID: 136232
    [Abstract] [Full Text] [Related]

  • 6. Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG, Green AR.
    Br J Pharmacol; 1974 Mar; 50(3):443P-446P. PubMed ID: 4277620
    [No Abstract] [Full Text] [Related]

  • 7. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG.
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract] [Full Text] [Related]

  • 8. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP, Grahame-Smith DG, Green AR, Tordoff AF.
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [Abstract] [Full Text] [Related]

  • 9. How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function?
    Grahame-Smith DG.
    Adv Biochem Psychopharmacol; 1974 Feb; 10():83-91. PubMed ID: 4367772
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological studies on serotonin-mediated behaviour.
    Green AR.
    J Physiol (Paris); 1981 Feb; 77(2-3):437-47. PubMed ID: 6457143
    [Abstract] [Full Text] [Related]

  • 11. The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypramine to rats pretreated with lithium or rubidium.
    Judd A, Parker J, Jenner FA.
    Psychopharmacologia; 1975 Apr 30; 42(1):73-7. PubMed ID: 1153625
    [Abstract] [Full Text] [Related]

  • 12. Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.
    Ashkenazi R, Finberg JP, Youdim MB.
    Br J Pharmacol; 1983 Jul 30; 79(3):765-70. PubMed ID: 6418248
    [Abstract] [Full Text] [Related]

  • 13. Role of brain amines in the fetal hyperpyrexia caused by tranylcypromine in LiCl-pretreated rats.
    Shimomura K, Hashimoto M, Mori J, Honda F.
    Jpn J Pharmacol; 1979 Apr 30; 29(2):161-70. PubMed ID: 161335
    [Abstract] [Full Text] [Related]

  • 14. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF, Green AR.
    Br J Pharmacol; 1978 Oct 30; 64(2):201-9. PubMed ID: 708990
    [Abstract] [Full Text] [Related]

  • 15. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW, Green AR.
    Br J Pharmacol; 1978 Oct 30; 64(2):193-200. PubMed ID: 30503
    [Abstract] [Full Text] [Related]

  • 16. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR, Grahame-Smith DG.
    Neuropharmacology; 1974 Nov 30; 13(10-11):949-59. PubMed ID: 4437730
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ, Marsden CA, Martin KF, Palfreyman MG.
    Br J Pharmacol; 1988 Feb 30; 93(2):303-10. PubMed ID: 2451963
    [Abstract] [Full Text] [Related]

  • 18. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR, DeSouza RJ, Davies EM, Cross AJ.
    Br J Pharmacol; 1990 Jan 30; 99(1):41-6. PubMed ID: 1691944
    [Abstract] [Full Text] [Related]

  • 19. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR, Hall JE, Rees AR.
    Br J Pharmacol; 1981 Jul 30; 73(3):703-19. PubMed ID: 6166345
    [Abstract] [Full Text] [Related]

  • 20. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--1. Rubidium.
    Wang H, Grahame-Smith DG.
    Neuropharmacology; 1992 May 30; 31(5):413-9. PubMed ID: 1382243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.